MedChem 2017
Conferences > Upcoming events > MedChem 2017
Friday December 1, 2017
08:00Registration
08:50Opening
Prof Piet HERDEWIJN
(KULEUVEN, Leuven, Belgium)
09:00PL01 - 2’-Spiro-substituted Nucleosides Active against the Hepatitis C-virus
Dr Tim JONCKERS
(JANSSEN INFECTIOUS DISEASES-DIAGNOSTICS BVBA, Beerse, Belgium)
09:50PL02 - Use of Cyclic Dinucleotides (CDNs) to Induce Stimulator of Interferon Genes (STING)-Dependent Antitumor Immunity
Dr Cedric BOULARAN
(INVIVOGEN, Toulouse, France)
10:40Coffee break and Exhibition
11:15OC01 - Unlock your Compound Management
Dr Jan BREITENFELD
(CHEMSPEED TECHNOLOGIES AG, Füllinsdorf, Switzerland)
11:35PL03 - Discovery of Novel DOT1L Inhibitors by Fragment Growing, Defragmentation and Fragment Linking
Dr Henrik MOEBITZ
(NOVARTIS, Basel, Switzerland)
12:25Lunch, Exhibition and Poster session
14:00PL04 - Antitumoral and Antiviral Nucleosides, siRNAs and shRNAs for Applications in vitro, in vivo and in Bioprinted 3D Organ Models
Prof. Jens KURRECK
(UNIVERSITY OF BERLIN, Berlin, Germany)
14:50OC02 - Novel 3'-Deoxy Purine Nucleoside Analogs as Highly Potent Leads for Human African Trypanosomiasis
Mr Fabian HULPIA
(UGENT, Ghent, Belgium)
15:10OC03 - New Genetic Systems with Four Non-Canonical Nucleobases: Biotechnology and Therapeutic Applications
Dr Elena EREMEEVA
(KU LEUVEN, Leuven, Belgium)
15:30Coffee break, Exhibition and Poster session
16:05PL05 - Synthetic Genetics: Beyond DNA and RNA
Dr Philipp HOLLIGER
(MRC LABORATORY OF MOLECULAR BIOLOGY, Cambridge, United Kingdom)
16:55PL06 - Large Scale Pooled Crispr Screening: Mining for the Deep
Dr Roderick BEIJERSBERGEN
(NETHERLANDS CANCER INSTITUTE, Amsterdam, The Netherlands)
17:45Closing Remarks

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys